Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2019-01-01
2020-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Direct Pulp Capping in Primary Molars
NCT05530954
Calcium Hydroxide Versus Premixed Bioceramic Putty in Direct Pulp Capping of Primary Molars
NCT05496257
Partial Versus Complete Pulpotomy Using Three Different Materials in Primary Molars: a Clinical Study
NCT05190783
Comparison of Mineral Trioxide Aggregate (MTA) and 20% Formocresol (FC) in Pulpotomized Human Primary Molars
NCT00972556
The Use of Platelet-Rich Fibrin in Partial Pulpotomy Procedure
NCT04331964
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Calcium hydroxide was introduced to the dental practice in the 1920s, and early clinical studies using it in direct pulp capping showed an 80-90 percent success rate.Recent studies with longer follow-up periods suggest lower success rates for it.Calcium hydroxide was used in many forms alone and mixed with other materials for many applications in the dental profession. For direct pulp capping calcium hydroxide powder and aqueous paste were used at first then premixed and cement-based types were developed.
Mineral trioxide aggregate (MTA) was introduced to the dental practice in the 1990s as a root-end filling material. MTA is used as a gold standard in endodontics and has a variety of applications such as root-end filling, apexification, root and truck perforations, apexogenesis, pulp capping in permanent and primary teeth, and dressing for pulpotomy in primary teeth. It is mainly composed of tricalcium silicate, tricalcium aluminate, dicalcium silicate, bismuth oxide, and calcium sulfate dehydrate.
Several studies have shown the efficacy of direct pulp capping using calcium hydroxide and MTA in permanent teeth. However, its use in primary teeth is controversial and few studies are available regarding that subject. Formocresol is not known to be used in direct pulp capping techniques, however, its high clinical success in pulpotomy techniques for primary teeth promoted the investigation of its possible use as direct capping medicament. In addition, there are not enough collected clinical and histological data about direct capping in primary teeth to assess the true success of treatment. Accordingly, the study was directed to evaluate the histological and clinical success of different materials in direct pulp capping for primary teeth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Calcium Hydroxide (CH)
Calcium Hydroxide is the gold standard for direct pulp capping depends on regeneration
Direct pulp capping with calcium hydroxide
Capping exposed dental pulps during cavity preparation in primary teeth with calcium hydroxide
MTA
Mineral trioxide aggregate used for pulp regeneration
Direct pulp capping with MTA
Capping exposed dental pulps during cavity preparation in primary teeth with MTA
Formocresol (FC)
composed of formaldehyde, cresol, glycerin and water used for fixation of pulp tissue
Direct pulp capping with Formocresol
Capping exposed dental pulps during cavity preparation in primary teeth with zinc oxide eugenol after medication with formocresol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Direct pulp capping with calcium hydroxide
Capping exposed dental pulps during cavity preparation in primary teeth with calcium hydroxide
Direct pulp capping with MTA
Capping exposed dental pulps during cavity preparation in primary teeth with MTA
Direct pulp capping with Formocresol
Capping exposed dental pulps during cavity preparation in primary teeth with zinc oxide eugenol after medication with formocresol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Absence of drug allergies, anesthetics, and environmental allergies.
3. Cooperative patients.
4. Restorable teeth with deep decay lesions.
5. Teeth with signs of reversible pulpitis; no spontaneous pain; and absence of edema, pain, fistula, pathological mobility, and sensitivity to percussion.
6. True pinpoint exposure (small exposure surrounded by sound dentin with normal bleeding easily controlled)
7. Teeth with no pathological root resorption, periradicular or furcal radiolucency.
8. Teeth with less than one-third physiological root resorption (no resorption or one-fourth resorption of the root).
Exclusion Criteria
4 Years
8 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura University
Al Mansurah, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05030718
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.